S6925 (2025-26 session)
NY State bill
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
- Title
- Relates to capping cost sharing for antiviral COVID-19 therapeutics
- Type
- New York State Senate bill
- Session
- 2025-26 session
- Status
- In Senate Committee
- Latest action date
- 2025-03-27
- In committee
- Insurance
- Introduced
- 2025-03-27
- Same as
- A3833
- Law section
- Insurance Law
Sponsors
Heard in committee
- Insurance NY State Senate committee
Same as
- A3833 (2025-26 session) NY State bill